Skip to main content
OpenTrials
Completed

NCT Number: NCT04912804

Perceived Health After Hospitalization for COVID-19

There are currently no precise data available on the impact of COVID-19 on the daily life of patients after hospitalization. For the moment, studies have only demonstrated a strong impact of the diagnosis on the domains of quality of life explored by the MOS-SF36 questionnaire and the PHQ-9 depression score. Concerning the impact of COVID-19 disease after conventional hospitalization, field reports indicate extremely intense fatigue and a major physical impact lasting several weeks

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19, Post-hospitalization, Disease Impact COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Dijon Bourogne

Dijon, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient
  • Patient with a diagnosis of COVID-19 confirmed by PCR and/or CT scan
  • Patient hospitalized in a short stay unit (excluding intensive care and rehabilitation) for a COVID-19 infection
  • Patient providing oral consent to participate in the study
  • Patient able to understand and answer the questionnaires used
  • Patient able to answer the questions on an electronic device and to receive requests by email and/or SMS
  • Patient who has electronic equipment at home and an Internet subscription allowing him/her to answer the questionnaires online

Exclusion criteria

  • Patient under guardianship, curatorship or a measure of judicial safeguard

Treatment and study plan

questionnaires

Other

SF-12, GHQ-12 and HAQ

Primary outcomes

  1. Time to PASS and CID in patients discharged from conventional hospitalization for COVID-19 disease

    Time frame: Through study completion, an average of 6 months

  2. The value of perceived health scores in patients who achieved PASS and MCII

    Time frame: Through study completion, an average of 6 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Acronym: PRO-COVID

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jun 3, 2021
Registry last updated
Apr 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.